Convenient selective intra-arterial continuous infusion chemotherapy via the superior thyroid artery for oral cancer

Hidetaka Yokoe , Yukio Yamano , Katsunori Ogawara , Hitomi Nomura , Makoto Nakatsuru , Yosuke Sakamoto , Atsushi Kasamatsu , Masashi Shiiba , Katsuhiro Uzawa , Yuichi Takiguchi , Hideki Tanzawa
{"title":"Convenient selective intra-arterial continuous infusion chemotherapy via the superior thyroid artery for oral cancer","authors":"Hidetaka Yokoe ,&nbsp;Yukio Yamano ,&nbsp;Katsunori Ogawara ,&nbsp;Hitomi Nomura ,&nbsp;Makoto Nakatsuru ,&nbsp;Yosuke Sakamoto ,&nbsp;Atsushi Kasamatsu ,&nbsp;Masashi Shiiba ,&nbsp;Katsuhiro Uzawa ,&nbsp;Yuichi Takiguchi ,&nbsp;Hideki Tanzawa","doi":"10.1016/j.ajoms.2010.08.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>We designed a convenient method of selective intra-arterial infusion chemotherapy to treat oral cancer with low-dose 5-fluorouracil.</p></div><div><h3>Patients and methods</h3><p>Twenty-seven primary cases treated with this method with concomitant external irradiation. The reasons for performing selective continuous intra-arterial infusion were severe systemic disease in four cases, advanced age in seven cases, unresectability in nine cases, preoperative chemotherapy in five cases, and two patients refused surgery.</p></div><div><h3>Results</h3><p>The overall treatment effects were as follows: complete response in 13 cases, partial response in 12 cases, and no change in two cases. None of the patients experienced disease progression while receiving concurrent chemoradiotherapy. Twenty-three toxic adverse events ranging from grades 1 to 4 developed in 25 patients. A grade 1 complication developed in six patients; oral and/or pharyngeal mucositis developed frequently in 12 patients. Hematologic adverse events such as leukocytopenia or thrombocytopenia were observed in five patients, but no grade 3 or 4 events developed in any patients.</p></div><div><h3>Conclusions</h3><p>These data indicated that our method is suitable for patients who cannot undergo surgery or systemic chemotherapy due to old age or severe systemic disease.</p></div>","PeriodicalId":100128,"journal":{"name":"Asian Journal of Oral and Maxillofacial Surgery","volume":"23 2","pages":"Pages 63-68"},"PeriodicalIF":0.0000,"publicationDate":"2011-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ajoms.2010.08.004","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Oral and Maxillofacial Surgery","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0915699211000379","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Objective

We designed a convenient method of selective intra-arterial infusion chemotherapy to treat oral cancer with low-dose 5-fluorouracil.

Patients and methods

Twenty-seven primary cases treated with this method with concomitant external irradiation. The reasons for performing selective continuous intra-arterial infusion were severe systemic disease in four cases, advanced age in seven cases, unresectability in nine cases, preoperative chemotherapy in five cases, and two patients refused surgery.

Results

The overall treatment effects were as follows: complete response in 13 cases, partial response in 12 cases, and no change in two cases. None of the patients experienced disease progression while receiving concurrent chemoradiotherapy. Twenty-three toxic adverse events ranging from grades 1 to 4 developed in 25 patients. A grade 1 complication developed in six patients; oral and/or pharyngeal mucositis developed frequently in 12 patients. Hematologic adverse events such as leukocytopenia or thrombocytopenia were observed in five patients, but no grade 3 or 4 events developed in any patients.

Conclusions

These data indicated that our method is suitable for patients who cannot undergo surgery or systemic chemotherapy due to old age or severe systemic disease.

经甲状腺上动脉的方便选择性动脉内持续输注化疗治疗口腔癌
目的设计小剂量5-氟尿嘧啶选择性动脉灌注化疗治疗口腔癌的简便方法。患者与方法采用该方法治疗原发性肿瘤27例,并辅以外照射。选择性动脉持续输注的原因为:全身性疾病严重4例,高龄7例,不可切除9例,术前化疗5例,拒绝手术2例。结果总疗效:完全缓解13例,部分缓解12例,无变化2例。在接受同步放化疗时,没有患者出现疾病进展。25例患者发生1至4级的23例毒性不良事件。6例患者出现1级并发症;口腔和/或咽部粘膜炎多发12例。在5例患者中观察到血液学不良事件,如白细胞减少或血小板减少,但没有任何患者发生3级或4级事件。结论本方法适用于因老年或严重全身性疾病不能行手术或全身化疗的患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信